金吾财讯 | 诺诚健华(09969)公告，一季度归属上市公司股东净利润为1796.76万元（人民币，下同），同比扭亏为盈，主要原因为营业收入大幅增加，上年同期为亏损1.42亿元；基本每股收益为0.01元。期内，营收为3.81亿元，同比增长129.92%，其中药品销售收入3.12亿元，同比增长89.11%。本期营业收入大幅增加，一方面系奥布替尼销售量持续增加所致；另一方面系与Prolium达成授权许可的首付款确认相关收入所致。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.